Covid Vaccine Sales Could Give $32 Billion In 2021 To Pfizer And Moderna
The impending emergency use authorization of Pfizer’s Covid-19 vaccine in the United States is a major money making ticket for the company and its partner in the vaccine development. Within the next year alone, $32 billion in revenues from sale of Covid-19 vaccines will be generated by Pfizer and Moderna, according to projections by Wall…









